Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2026-02-09 @ 11:11 PM
Study NCT ID:
NCT02242656
Status:
WITHDRAWN
Last Update Posted:
2015-02-18
First Post:
2014-09-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Investigational Product MP-101 in Subjects With Short Bowel Syndrome Who Have Had an Inadequate Response to Anti-Diarrheals
Sponsor:
Marathon Pharmaceuticals, LLC
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Short Bowel Syndrome | View |
| None | SBS | View |
| None | Chronic Diarrhea | View |
| None | Short Bowel | View |
| None | Short Gut | View |
| None | Short Gut Syndrome | View |
| None | Anti-Diarrheal | View |
| None | Opium Tincture | View |
| None | loperamide | View |
| None | diphenoxylate | View |
| None | ileostomies | View |
| None | tincture of opium | View |
| None | DTO | View |
| None | codeine | View |
| None | morphine | View |
| None | opiate | View |